NCT02248844View on ClinicalTrials.gov

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

CompletedOBSERVATIONAL
Enrollment

667

Participants

Timeline

Start Date

September 26, 2014

Primary Completion Date

August 14, 2017

Study Completion Date

August 14, 2017

Conditions
Lateral Canthal LinesCrow's Feet Lines
Interventions
BIOLOGICAL

Botulinum Toxin Type A

Botulinum toxin Type A injected into crow's feet line areas per clinical practice.

Trial Locations (1)

135-839

Dr. Robbin Clinic, Gangnam-gu

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT02248844 - Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea | Biotech Hunter | Biotech Hunter